173 related articles for article (PubMed ID: 32322212)
21. MiR-129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancer.
Xu S; Ge J; Zhang Z; Zhou W
Biomed Pharmacother; 2017 Dec; 96():634-641. PubMed ID: 29035829
[TBL] [Abstract][Full Text] [Related]
22. Corrigendum: Hydroxychloroquine attenuates autoimmune hepatitis by suppressing the interaction of GRK2 with PI3K in T lymphocytes.
Jin C; Gao BB; Zhou WJ; Zhao BJ; Fang X; Yang CL; Wang XH; Xia Q; Liu TT
Front Pharmacol; 2023; 14():1322549. PubMed ID: 38027022
[TBL] [Abstract][Full Text] [Related]
23. Corrigendum:
Wu D; Wang Z; Lin M; Shang Y; Wang F; Zhou J; Wang F; Zhang X; Luo X; Huang W
Front Pharmacol; 2024; 15():1334971. PubMed ID: 38505422
[TBL] [Abstract][Full Text] [Related]
24. Corrigendum: Shikonin Inhibits Cancer Through P21 Upregulation and Apoptosis Induction.
Wang F; Mayca Pozo F; Tian D; Geng X; Yao X; Zhang Y; Tang J
Front Pharmacol; 2020; 11():1088. PubMed ID: 32765281
[TBL] [Abstract][Full Text] [Related]
25. shRNA-interfering LSD1 inhibits proliferation and invasion of gastric cancer cells
Pan HM; Lang WY; Yao LJ; Wang Y; Li XL
World J Gastrointest Oncol; 2019 Aug; 11(8):622-633. PubMed ID: 31435463
[TBL] [Abstract][Full Text] [Related]
26. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion.
Shukla S; Maclennan GT; Hartman DJ; Fu P; Resnick MI; Gupta S
Int J Cancer; 2007 Oct; 121(7):1424-32. PubMed ID: 17551921
[TBL] [Abstract][Full Text] [Related]
27. Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells.
Pfeil K; Eder IE; Putz T; Ramoner R; Culig Z; Ueberall F; Bartsch G; Klocker H
Prostate; 2004 Feb; 58(3):259-68. PubMed ID: 14743465
[TBL] [Abstract][Full Text] [Related]
28. Effect of PI3K/Akt Signaling Pathway on the Process of Prostate Cancer Metastasis to Bone.
Zhu W; Hu X; Xu J; Cheng Y; Shao Y; Peng Y
Cell Biochem Biophys; 2015 May; 72(1):171-7. PubMed ID: 27040945
[TBL] [Abstract][Full Text] [Related]
29. Corrigendum: Doxycycline Inhibits Cancer Stem Cell-Like Properties
Liu H; Tao H; Wang H; Yang Y; Yang R; Dai X; Ding X; Wu H; Chen S; Sun T
Front Oncol; 2022; 12():830506. PubMed ID: 35280769
[TBL] [Abstract][Full Text] [Related]
30. GOLM1 promotes prostate cancer progression through activating PI3K-AKT-mTOR signaling.
Yan G; Ru Y; Wu K; Yan F; Wang Q; Wang J; Pan T; Zhang M; Han H; Li X; Zou L
Prostate; 2018 Feb; 78(3):166-177. PubMed ID: 29181846
[TBL] [Abstract][Full Text] [Related]
31. Apatinib suppresses the Proliferation and Apoptosis of Gastric Cancer Cells via the PI3K/Akt Signaling Pathway.
Jia X; Wen Z; Sun Q; Zhao X; Yang H; Shi X; Xin T
J BUON; 2019; 24(5):1985-1991. PubMed ID: 31786865
[TBL] [Abstract][Full Text] [Related]
32. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
33. Eriodictyol Inhibits Proliferation, Metastasis and Induces Apoptosis of Glioma Cells
Li W; Du Q; Li X; Zheng X; Lv F; Xi X; Huang G; Yang J; Liu S
Front Pharmacol; 2020; 11():114. PubMed ID: 32158391
[TBL] [Abstract][Full Text] [Related]
34. Anti-proliferative and apoptosis inducing effect of nimbolide by altering molecules involved in apoptosis and IGF signalling via PI3K/Akt in prostate cancer (PC-3) cell line.
Raja Singh P; Arunkumar R; Sivakamasundari V; Sharmila G; Elumalai P; Suganthapriya E; Brindha Mercy A; Senthilkumar K; Arunakaran J
Cell Biochem Funct; 2014 Apr; 32(3):217-28. PubMed ID: 23963693
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-520a-3p inhibits cell growth and metastasis of non-small cell lung cancer through PI3K/AKT/mTOR signaling pathway.
Lv X; Li CY; Han P; Xu XY
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2321-2327. PubMed ID: 29762835
[TBL] [Abstract][Full Text] [Related]
36. Desumoylating Isopeptidase 2 (DESI2) Inhibits Proliferation and Promotes Apoptosis of Pancreatic Cancer Cells through Regulating PI3K/AKT/mTOR Signaling Pathway.
Ou X; Zhang GT; Xu Z; Chen JS; Xie Y; Liu JK; Liu XP
Pathol Oncol Res; 2019 Apr; 25(2):635-646. PubMed ID: 30411297
[TBL] [Abstract][Full Text] [Related]
37. Corrigendum: Cucurbitacin-B instigates intrinsic apoptosis and modulates Notch signaling in androgen-dependent prostate cancer LNCaP cells.
Alafnan A; Khalifa NE; Hussain T; Osman ME
Front Pharmacol; 2023; 14():1286507. PubMed ID: 37841925
[TBL] [Abstract][Full Text] [Related]
38. Corrigendum: Berberine and Oligomeric Proanthocyanidins Exhibit Synergistic Efficacy Through Regulation of PI3K-Akt Signaling Pathway in Colorectal Cancer.
Okuno K; Garg R; Yuan YC; Tokunaga M; Kinugasa Y; Goel A
Front Oncol; 2022; 12():952180. PubMed ID: 35847926
[TBL] [Abstract][Full Text] [Related]
39. Naringin inhibits colorectal cancer cell growth by repressing the PI3K/AKT/mTOR signaling pathway.
Cheng H; Jiang X; Zhang Q; Ma J; Cheng R; Yong H; Shi H; Zhou X; Ge L; Gao G
Exp Ther Med; 2020 Jun; 19(6):3798-3804. PubMed ID: 32346444
[TBL] [Abstract][Full Text] [Related]
40. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
Li Y; Ma X; Wang Y; Li G
Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
